1-4 of 4
Kathryn Beal
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Genomic Correlates of Disease Progression and Treatment Response in Prospectively Characterized Gliomas

Philip Jonsson, Andrew L. Lin, Robert J. Young, Natalie M. DiStefano, David M. Hyman, Bob T. Li, Michael F. Berger, Ahmet Zehir, Marc Ladanyi, David B. Solit, Angela G. Arnold, Zsofia K. Stadler, Diana Mandelker, Michael E. Goldberg, Juliann Chmielecki, Maryam Pourmaleki, Shahiba Q. Ogilvie, Shweta S. Chavan, Andrew T. McKeown, Malbora Manne, Allison Hyde, Kathryn Beal, T. Jonathan Yang, Craig P. Nolan, Elena Pentsova, Antonio Omuro, Igor T. Gavrilovic, Thomas J. Kaley, Eli L. Diamond, Jacqueline B. Stone, Christian Grommes, Adrienne Boire, Mariza Daras, Anna F. Piotrowski, Alexandra M. Miller, Philip H. Gutin, Timothy A. Chan, Viviane S. Tabar, Cameron W. Brennan, Marc Rosenblum, Lisa M. DeAngelis, Ingo K. Mellinghoff, Barry S. Taylor
Journal: Clinical Cancer Research
Series: Author Choice
Clin Cancer Res (2019) 25 (18): 5537–5547.
https://doi.org/10.1158/1078-0432.CCR-19-0032
Published: 13 September 2019
View article titled, Genomic Correlates of Disease Progression and Treatment Response in Prospectively Characterized Gliomas
Open the PDF for Genomic Correlates of Disease Progression and Treatment Response in Prospectively Characterized Gliomas in another window
Includes: Supplementary data
Journal Articles

Residual Tumor Volume, Cell Volume Fraction, and Tumor Cell Kill During Fractionated Chemoradiation Therapy of Human Glioblastoma using Quantitative Sodium MR Imaging

Keith R. Thulborn, Aiming Lu, Ian C. Atkinson, Mohan Pauliah, Kathryn Beal, Timothy A. Chan, Antonio Omuro, Josh Yamada, Michelle S. Bradbury
Journal: Clinical Cancer Research
Clin Cancer Res (2019) 25 (4): 1226–1232.
https://doi.org/10.1158/1078-0432.CCR-18-2079
Published: 15 February 2019
View article titled, Residual Tumor Volume, Cell Volume Fraction, and Tumor Cell Kill During Fractionated Chemoradiation Therapy of Human Glioblastoma using Quantitative Sodium MR Imaging
Open the PDF for Residual Tumor Volume, Cell Volume Fraction, and Tumor Cell Kill During Fractionated Chemoradiation Therapy of Human Glioblastoma using Quantitative Sodium MR Imaging in another window
Journal Articles

Molecular and Clinical Effects of Notch Inhibition in Glioma Patients: A Phase 0/I Trial

Ran Xu, Fumiko Shimizu, Koos Hovinga, Kathryn Beal, Sasan Karimi, Leif Droms, Kyung K. Peck, Philip Gutin, J. Bryan Iorgulescu, Thomas Kaley, Lisa DeAngelis, Elena Pentsova, Craig Nolan, Christian Grommes, Timothy Chan, Dylan Bobrow, Adilia Hormigo, Justin R. Cross, Nian Wu, Naoko Takebe, Katherine Panageas, Percy Ivy, Jeffrey G. Supko, Viviane Tabar, Antonio Omuro
Journal: Clinical Cancer Research
Clin Cancer Res (2016) 22 (19): 4786–4796.
https://doi.org/10.1158/1078-0432.CCR-16-0048
Published: 02 October 2016
View article titled, Molecular and Clinical Effects of Notch Inhibition in Glioma Patients: A Phase 0/I Trial
Open the PDF for Molecular and Clinical Effects of Notch Inhibition in Glioma Patients: A Phase 0/I Trial in another window
Includes: Supplementary data
Journal Articles

Phase II Study of Bevacizumab, Temozolomide, and Hypofractionated Stereotactic Radiotherapy for Newly Diagnosed Glioblastoma

Antonio Omuro, Kathryn Beal, Philip Gutin, Sasan Karimi, Denise D. Correa, Thomas J. Kaley, Lisa M. DeAngelis, Timothy A. Chan, Igor T. Gavrilovic, Craig Nolan, Adilia Hormigo, Andrew B. Lassman, Ingo Mellinghoff, Christian Grommes, Anne S. Reiner, Katherine S. Panageas, Raymond E. Baser, Viviane Tabar, Elena Pentsova, Juan Sanchez, Renata Barradas-Panchal, Jianan Zhang, Geraldine Faivre, Cameron W. Brennan, Lauren E. Abrey, Jason T. Huse
Journal: Clinical Cancer Research
Clin Cancer Res (2014) 20 (19): 5023–5031.
https://doi.org/10.1158/1078-0432.CCR-14-0822
Published: 30 September 2014
View article titled, Phase II Study of Bevacizumab, Temozolomide, and Hypofractionated Stereotactic Radiotherapy for Newly Diagnosed Glioblastoma
Open the PDF for Phase II Study of Bevacizumab, Temozolomide, and Hypofractionated Stereotactic Radiotherapy for Newly Diagnosed Glioblastoma in another window
Includes: Supplementary data